Opportunities for CAR-T Cell Immunotherapy in HIV Cure

Chimeric antigen receptor (CAR) technology is having a huge impact in the blood malignancy field and is becoming a well-established therapy for many types of leukaemia. In recent decades, efforts have been made to demonstrate that CAR-T cells have potential as a therapy to achieve a sterilizing cure...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos-Gonzalez, Gerard, Martinez-Picado, Javier, Velasco-Hernandez, Talia, Salgado, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057306/
https://www.ncbi.nlm.nih.gov/pubmed/36992496
http://dx.doi.org/10.3390/v15030789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057306/
https://www.ncbi.nlm.nih.gov/pubmed/36992496
http://dx.doi.org/10.3390/v15030789

Ejemplares similares